Pages that link to "10 CFR 35.2, Definitions"
Jump to navigation
Jump to search
The following pages link to 10 CFR 35.2, Definitions:
Displayed 50 items.
- 10 CFR 35.2 (redirect page) (← links)
- 10 CFR 32.72 (← links)
- 10 CFR 35 (← links)
- ML062550222 (← links)
- ML12228A606 (← links)
- ML063110176 (← links)
- RIS 2007-27, Improving Public Understanding of the Risks Associated with Medical Events (← links)
- RIS 2006-26, SECY-06-0248 Enclosure 2 - Regulatory Issue Summary 2006-26, Training and Experience and Grandfather Provisions for Authorized Medical Physicists Under 10 CFR Part 35 (← links)
- RIS 2006-26, Training and Experience and Grandfather Provisions for Authorized Medical Physicists Under 10 CFR 35 (← links)
- ML17268A259 (← links)
- ML102320068 (← links)
- ML100970368 (← links)
- ML092930273 (← links)
- ML18218A436 (← links)
- ML18226A161 (← links)
- ML18198A067 (← links)
- ML18176A377 (← links)
- ML18176A094 (← links)
- ML18248A022 (← links)
- ML18073A209 (← links)
- ML18053A770 (← links)
- ML18030B357 (← links)
- ML003739396 (← links)
- ML003739383 (← links)
- ML003739377 (← links)
- ML18218A263 (← links)
- ML053190234 (← links)
- ML18284A483 (← links)
- ML18331A169 (← links)
- ML19081A145 (← links)
- ML19091A240 (← links)
- ML19085A550 (← links)
- NUREG-1556 Volume 13, Rev 2 - Consolidated Guidance About Materials Licenses - Program-Specific Guidance About Commercial Radiopharmacy Licenses - Final Report (← links)
- NUREG-0090 Volume 40, Report to Congress on Abnormal Occurrences - Fiscal Year 2017. (← links)
- ML19114A546 (← links)
- ML19130A103 (← links)
- NUREG-1556 Volume 12, Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Possession Licenses for Manufacturing and Distribution (← links)
- ML003776487 (← links)
- ML003771757 (← links)
- ML003742170 (← links)
- ML003700730 (← links)
- ML003700254 (← links)
- ML19108A463 (← links)
- ML19178A323 (← links)
- SECY-19-0024, VR-SECY-19-0024: Report to Congress on Abnormal Occurrences: Fiscal Year 2018 (← links)
- NUREG-1556 Volume 9, Rev. 3, Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Medical Use Licenses Final Report (← links)
- ML19224A407 (← links)
- ML14204A616 (← links)
- ML19304B440 (← links)
- ML19297H316 (← links)
- ML19316E067 (← links)
- ML19204A272 (← links)
- ML19338E099 (← links)
- ML19322A311 (← links)
- ML19259A112 (← links)
- ML20056E123 (← links)
- ML20056D981 (← links)
- ML20055E820 (← links)
- ML20078M712 (← links)
- ML20075A028 (← links)
- ML20080J208 (← links)
- ML20115E395 (← links)
- ML20100K680 (← links)
- ML20098B297 (← links)
- ML20097F476 (← links)
- ML20090J586 (← links)
- ML20106B273 (← links)
- ML20113H726 (← links)
- ML20141L630 (← links)
- ML20137W713 (← links)
- ML20137U508 (← links)
- ML20137L574 (← links)
- ML20137D038 (← links)
- ML20137B985 (← links)
- ML20136J471 (← links)
- ML20136G543 (← links)
- ML20135E792 (← links)
- NUREG-0090 Volume 42, Report to Congress on Abnormal Occurrences, Fiscal Year 2019 (← links)
- ML20148J290 (← links)
- ML20148H059 (← links)
- ML20148G192 (← links)
- ML20141G739 (← links)
- ML20141A440 (← links)
- PNO-IV-97-036, on 970616,licensee Began Brachytherapy Procedure to Treat Patient for Cervical Cancer.Licensee Calculated That Patient May Have Received Max Dose of 400-500 Millirads to Skin (← links)
- ML20140B882 (← links)
- ML20138P917 (← links)
- ML20138L199 (← links)
- ML20138H665 (← links)
- ML20138G483 (← links)
- ML20138D416 (← links)
- ML20134N489 (← links)
- ML20134M009 (← links)
- ML20134G164 (← links)
- ML20134B897 (← links)
- ML20134B430 (← links)
- ML20133N716 (← links)
- ML20133B525 (← links)
- ML20132F529 (← links)
- ML20132B277 (← links)
- ML20129H453 (← links)
- ML20129B462 (← links)
- ML20128P437 (← links)
- ML20128P430 (← links)
- ML20127C388 (← links)
- ML20127C212 (← links)
- ML20126M574 (← links)
- ML20126H990 (← links)
- ML20126D837 (← links)
- ML20262H140 (← links)
- ML20261H504 (← links)
- ML20154E385 (← links)
- ML20151Z047 (← links)
- ML20149H284 (← links)
- ML20149H115 (← links)
- ML20149H103 (← links)
- ML20149F975 (← links)
- ML20199H266 (← links)
- ML20199B467 (← links)
- ML20198S375 (← links)
- ML20198K217 (← links)
- ML20198E561 (← links)
- ML20205J674 (← links)
- ML20204J489 (← links)
- ML20196K019 (← links)
- ML20281A519 (← links)
- ML20209C923 (← links)
- ML20325A190 (← links)
- ML20322A018 (← links)
- ML20317A253 (← links)
- ML20310A285 (← links)
- ML20310A237 (← links)
- ML20245A088 (← links)
- ML20338A535 (← links)
- ML20249B895 (← links)
- ML20247H963 (← links)
- ML20247G920 (← links)
- ML20247E463 (← links)
- ML20245F077 (← links)
- ML20236U166 (← links)
- ML20236T752 (← links)
- ML20236T728 (← links)
- ML20236T485 (← links)
- ML20236T482 (← links)
- ML20236S376 (← links)
- ML20236P178 (← links)
- ML20236L843 (← links)
- ML20236H854 (← links)
- ML21005A394 (← links)
- ML20235F945 (← links)
- ML20234E973 (← links)
- ML20217Q721 (← links)
- IA-98-125, Final Response to FOIA Request for Documents.Documents Listed in App a Encl & Being Made Available to Public in Entirety (← links)
- ML20217P716 (← links)
- ML20217P404 (← links)
- ML20217M952 (← links)
- ML20217M165 (← links)
- ML20217M127 (← links)
- PNO-III-98-028, on 980323,misadministration Occurred Involving Treatments to Wrong Side of Patient Vagina. Licensee Notified NRC on 980324.Medical Consultant Agreed to Review Event & NRC Inspector Will Conduct Special Insp (← links)
- ML20217C944 (← links)
- ML20216J673 (← links)
- ML21089A364 (← links)
- ML20211L323 (← links)
- NUREG-0090 Volume 43, Report to Congress on Abnormal Occurrences, Fiscal Year 2020 (← links)
- ML21159A115 (← links)
- ML20210N005 (← links)
- ML21354A472 (← links)
- DT-22-02, Management Directive 8.10, NRC Assessment Program for a Medical Event or an Incident Occurring at a Medical Facility (← links)
- NUREG-0090 Volume 44, Report to Congress on Abnormal Occurrences Fiscal Year 2021 (← links)
- SECY-22-0046, SRM-SECY-22-0046: Enclosure 1 - Report to Congress on Abnormal Occurrences: Fiscal Year 2021 (← links)
- VR-SECY-22-0046, Report to Congress on Abnormal Occurrences: Fiscal Year 2021 (Hanson) (← links)
- ML22209A154 (← links)
- ML22186A146 (← links)
- ML21153A074 (← links)
- ML22280A002 (← links)
- ML22278A183 (← links)
- ML22334A269 (← links)
- ML22334A102 (← links)
- ML22326A362 (← links)
- ML22322A157 (← links)
- ML23033A108 (← links)
- ML23026A215 (← links)
- ML23122A118 (← links)
- NUREG-0090 Volume 45, Report to Congress on Abnormal Occurrences, Fiscal Year 2022 (← links)
- ML23156A470 (← links)
- ML23156A420 (← links)
- ML23156A127 (← links)
- ML23156A040 (← links)
- ML23153A040 (← links)
- ML23153A038 (← links)
- ML23151A419 (← links)
- ML23122A356 (← links)
- NUREG-0090, SECY-23-0019: Enclosure 1 - NUREG-0090, Volume 45, Report to Congress on Abnormal Occurrences Fiscal Year 2022 (← links)
- ML23205A181 (← links)
- ML23240A718 (← links)
- ML23233A180 (← links)
- ML23269A235 (← links)
- ML23257A263 (← links)
- 10 CFR 35 (← links)
- 10 CFR 35.1, Purpose and Scope (← links)
- 10 CFR 35.5, Maintenance of Records (← links)
- 10 CFR 35.6, Provisions for the Protection of Human Research Subjects (← links)
- 10 CFR 35.7, Fda, Other Federal, and State Requirements (← links)
- 10 CFR 35.8, Information Collection Requirements: Omb Approval (← links)
- 10 CFR 35.10, Implementation (← links)
- 10 CFR 35.11, License Required (← links)
- 10 CFR 35.12, Application for License, Amendment, Or Renewal (← links)
- 10 CFR 35.13, License Amendments (← links)
- 10 CFR 35.14, Notifications (← links)
- 10 CFR 35.15, Exemptions Regarding Type a Specific Licenses of Broad Scope (← links)
- 10 CFR 35.18, License Issuance (← links)
- 10 CFR 35.19, Specific Exemptions (← links)
- 10 CFR 35.24, Authority and Responsibilities for the Radiation Protection Program (← links)
- 10 CFR 35.26, Radiation Protection Program Changes (← links)
- 10 CFR 35.27, Supervision (← links)
- 10 CFR 35.40, Written Directives (← links)
- 10 CFR 35.41, Procedures for Administrations Requiring a Written Directive (← links)
- 10 CFR 35.49, Suppliers for Sealed Sources Or Devices for Medical Use (← links)
- 10 CFR 35.50, Training for Radiation Safety Officer (← links)
- 10 CFR 35.51, Training for an Authorized Medical Physicist (← links)
- 10 CFR 35.55, Training for an Authorized Nuclear Pharmacist (← links)
- 10 CFR 35.57, Training for Experienced Radiation Safety Officer, Teletherapy Or Medical Physicist, Authorized Medical Physicist, Authorized User, Nuclear Pharmacist, and Authorized Nuclear Pharmacist (← links)
- 10 CFR 35.59, Recentness of Training (← links)
- 10 CFR 35.60, Possession, Use, and Calibration of Instruments Used to Measure the Activity of Unsealed Byproduct Material (← links)
- 10 CFR 35.61, Calibration of Survey Instruments (← links)
- 10 CFR 35.63, Determination of Dosages of Unsealed Byproduct Material for Medical Use (← links)
- 10 CFR 35.65, Authorization for Calibration, Transmission, and Reference Sources (← links)
- 10 CFR 35.67, Requirements for Possession of Sealed Sources and Brachytherapy Sources (← links)
- 10 CFR 35.69, Labeling of Vials and Syringes (← links)
- 10 CFR 35.70, Surveys of Ambient Radiation Exposure Rate (← links)
- 10 CFR 35.75, Release of Individuals Containing Unsealed Byproduct Material Or Implants Containing Byproduct Material (← links)
- 10 CFR 35.80, Provision of Mobile Medical Service (← links)
- 10 CFR 35.92, Decay-In-Storage (← links)
- 10 CFR 35.100, Use of Unsealed Byproduct Material for Uptake, Dilution, and Excretion Studies for Which a Written Directive Is Not Required (← links)
- 10 CFR 35.190, Training for Uptake, Dilution, and Excretion Studies (← links)
- 10 CFR 35.200, Use of Unsealed Byproduct Material for Imaging and Localization Studies for Which a Written Directive Is Not Required (← links)
- 10 CFR 35.204, Permissible Molybdenum-99, Strontium-82, and Strontium-85 Concentrations (← links)
- 10 CFR 35.290, Training for Imaging and Localization Studies (← links)
- 10 CFR 35.300, Use of Unsealed Byproduct Material for Which a Written Directive Is Required (← links)
- 10 CFR 35.310, Safety Instruction (← links)
- 10 CFR 35.315, Safety Precautions (← links)
- 10 CFR 35.390, Training for Use of Unsealed Byproduct Material for Which a Written Directive Is Required (← links)
- 10 CFR 35.392, Training for the Oral Administration of Sodium Iodide I-131 Requiring a Written Directive In Quantities Less Than Or Equal to 1.22 Gigabecquerels (33 Millicuries) (← links)
- 10 CFR 35.394, Training for the Oral Administration of Sodium Iodide I-131 Requiring a Written Directive In Quantities Greater Than 1.22 Gigabecquerels (33 Millicuries) (← links)
- 10 CFR 35.400, Use of Sources for Manual Brachytherapy (← links)
- 10 CFR 35.404, Surveys After Source Implant and Removal (← links)
- 10 CFR 35.406, Brachytherapy Sources Accountability (← links)